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In the era of evidence-based medicine, health authorities are 
obligated to base policies on solid evidence. The gold standard of 
evidence-based medicine is the randomised controlled trial (RCT) in 
which participants fulfil strict criteria for inclusion, and the ecology 
of care – i.e. factors other than the intervention that could influence 
the outcome are controlled.[1] However, evidence supporting systems 
interventions in health services that involve multiple changes in the 
delivery of services is complex and requires the synthesis of evidence 
from multiple sources. Not surprisingly, such evidence is scarcest in 
the resource-constrained settings that need it most, where issues of 
prioritisation and cost-effectiveness are of paramount importance.
This dilemma facing health authorities is well illustrated by 
circumstances surrounding the adoption of Adult Primary Care 
(APC) by the National Department of Health for use in primary care 
facilities in South Africa (SA), which forms part of the Ideal Clinic 
initiative.[2] APC is the new name for Primary Care 101 (PC101), 
developed by the Knowledge Translation Unit at the University of 
Cape Town Lung Institute, after more than a decade of formative 
research. APC is a comprehensive clinical management guide and 
training approach for frontline clinicians (in SA, usually nurses), 
providing simple algorithms for the integrated management of 
multiple conditions; in fact the majority of reasons for which adult 
patients attend primary care facilities, including preventive, curative 
and chronic care.[3] What evidence might the health authorities have 
considered in adopting the APC approach, particularly in the face of 
the recent publication, in a high-impact journal, of a large pragmatic 
randomised trial conducted in 38 clinics in the Eden and Overberg 
districts of SA, which failed to show significant improvement in the 
management of three non-communicable diseases (NCDs) and case 
detection of depression following the introduction of PC101?[4] What 
other factors might the health authorities have considered in making 
this decision?
First, it should be noted that the decision predated the availability 
of the results of the PC101 trial. We argue that there are at least three 
reasons why the decision remains appropriate: (i) methodological 
issues in pragmatic controlled trials such as the PC101 trial; (ii) 
additional evidence supporting the effectiveness of PC101; and (iii) 
the role of evidence in shaping health system reform.
In the continuum of research methods from observational studies 
to randomised trials, the pragmatic trial comes close to ‘real-
life’ conditions while retaining the advantages of randomisation 
and preservation of internal validity. Explanatory RCTs, where 
interventions are tested under tightly controlled conditions, are 
useful to decision-makers when they produce negative results, as 
interventions that do not work under ideal conditions are unlikely 
to be effective when applied in real-world settings, and so can be 
abandoned. When they produce positive findings, questions arise as 
to whether they will yield similar results under routine circumstances 
where, for example, adherence is usually far lower than what was 
achieved in the trial. Conversely, positive pragmatic trials provide 
compelling evidence of usefulness and should prompt adoption. 
When negative, further research remains an option, particularly if, as 
in the PC101 trial, there is no evidence of harm.[5]
The PC101 trial was ambitious in its pragmatic orientation 
and affected by the unpredictable impact of real-life conditions. 
It focused on the intensification of prescribing for three NCDs – 
hypertension, diabetes and chronic respiratory diseases – and case 
detection of depression, while adopting a ‘hands-off ’ approach to 
assessing the validity of correct diagnosis, eligibility for treatment 
intensification, underlying disease severity, or patient adherence to 
treatment. Furthermore, factors external to the trial played a role. 
For example, during the trial, the district health authorities, in part 
inspired by a renewed focus on NCDs that accompanied PC101, 
implemented a Chronic Disease Season to encourage recognition 
and treatment of NCDs in all clinics, including 17 control clinics in 
the Eden district.
These and other issues described in the main publication probably 
accounted for the negative results for the primary endpoints. 
However, notably, analysis of prespecified subgroups – patients with 
poor control of diabetes and those with highest blood pressures – 
benefited significantly from the intervention.[4]
The challenges of designing and performing pragmatic controlled 
trials of complex interventions such as PC101, together with the 
scarcity or small size of positive outcomes, explain their rarity, 
particularly in low-income settings. But the PC101 trial is the latest of 
a succession of research reported by the Knowledge Translation Unit 
in more than 30 publications over 12 years. This research includes 
three other pragmatic randomised trials that showed consistent, 
reproducible improvements in both process and health outcomes, 
particularly for infectious diseases.[6-8] The PC101 trial must therefore 
be seen in the context of a growing experience of integrated nurse-
led primary care, in what has recently been described as a Learning 
Health System approach.[9] The Learning Health System is one that 
aims ‘to integrate delivery of health services with the generation of 
new knowledge about the effectiveness of these services’. Since the 
first version of PC101 (initially called the Practical Approach to Lung 
Health in South Africa – PALSA), results from studies of varying 
design – observational, qualitative, cost-effectiveness, and pragmatic 
randomised controlled trials – have been used to improve and expand 
the clinical guide and training methods. Further trials are underway 
in North West Province, SA (testing a strengthened mental health 
component of APC) and in Brazil (testing a Brazilian adaptation). 
The utility and role of APC should therefore not be invalidated by the 
results of one negative trial.
Finally, how might health authorities weigh evidence from various 
sources in their important policy decisions? An evidence hierarchy 
should place pragmatic trials performed in the target health facilities 
and embedded in usual practice as the highest level of evidence. 
Sadly, because pragmatic trials are complex and their results often 
challenging to interpret, decision-makers rely on findings from 
less robust research designs such as before-and-after observational 
studies. Supportive evidence from research by an independent 
party provides further assurance for decision-makers. PC101 was 
subjected to a controlled before-and-after study with a limited survey 
of impact on nurse knowledge and quality of care in 42 clinics in 
three health districts of SA. Findings were broadly positive across 
a range of process outcomes. Furthermore, since quality care can 
only be delivered by trained and motivated staff, qualitative research 
and audit confirming the rapid and enthusiastic uptake and rollout 
among healthcare workers of the APC approach, including most 
recently among undergraduate doctors, also serve as validation of 
the approach.
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What other factors require consideration? Cost and competing 
priorities are major factors in decision-making. Although a formal 
cost-consequence analysis of PC101 has not been completed, previous 
research results point to little if any additional cost, other than that 
relating to treatment related to improved detection of infectious 
disease.[10]
The attractiveness of the approach in implementing APC is 
that it utilises existing staff and staff trainers, and simply involves 
standardisation of clinical management and healthcare worker 
training. The training programme employs adult learning principles 
that increase confidence and strengthen self-perceived efficacy of 
healthcare workers. Furthermore, regular updates of the clinical 
management guide avoid the confusion of outdated guidelines 
and policies. The lack of alternatives to address the heavy load and 
multimorbidity faced by frontline clinicians, reflecting the collision 
of SA’s infectious disease and NCD epidemics, supports the adoption 
and implementation of APC. More than 80% of this load is borne by 
nurses in primary care in SA, a burden for which they often feel ill 
equipped. APC is designed around their needs and scope of practice, 
customised for their use in the clinic and compliant with all policies, 
and, importantly, harmonises conflicting instructions in different 
official guidelines.
Health systems research is a challenging but vital component of 
healthcare delivery, especially in resource-constrained settings, in 
which bad choices are both wasteful and deny care to those who 
need it. Results of a single well-conducted pragmatic controlled 
trial are of unquestionable value, but the evidence gap is best 
addressed by a Learning Health System – a continuous programme 
of research designed to generate and apply best evidence and then 
rigorously evaluate its effectiveness. Such a programme requires 
long-term collaborations between researchers, healthcare system 
and authorities ‘to drive the process of discovery as a natural 
outgrowth of patients’ care; and to ensure innovation, quality, safety 
and value in health care’.[11]
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